The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore
about
Many stimuli pull the necrotic trigger, an overviewAn outline of necrosome triggersFueling the flames: Mammalian programmed necrosis in inflammatory diseasesRegulated necrotic cell death: the passive aggressive side of Bax and BakThe role of necroptosis in neurosurgical diseasesThe NAD-dependent deacetylase SIRT2 is required for programmed necrosisNecrostatin-1 rescues mice from lethal irradiationReceptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis.Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia.Protein Kinase Signaling at the Crossroads of Myocyte Life and Death in Ischemic Heart Disease.The complex interplay between autophagy, apoptosis, and necrotic signals promotes T-cell homeostasis.Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI.RIP kinases: key decision makers in cell death and innate immunity.The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice.High-fat diet-induced adipocyte cell death occurs through a cyclophilin D intrinsic signaling pathway independent of adipose tissue inflammationCardiomyocyte death: mechanisms and translational implicationsNecroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death.Using Small Molecules to Dissect Non-apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis.NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells.Past, present, and future of molecular and cellular oncologyProgrammed Necrosis: A Prominent Mechanism of Cell Death following Neonatal Brain InjuryThe dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis.Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease modelsProtective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in miceMechanisms of cell death in heart disease.Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke.Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1.Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease.Neuronal cell death in neonatal hypoxia-ischemia.Necroptosis, necrostatins and tissue injury.Necroptosis: biochemical, physiological and pathological aspects.Cell death in the myocardium: my heart won't go on.Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.TNF-α-induced programmed cell death in the pathogenesis of acquired aplastic anemia.Chronic heart failure: Ca(2+), catabolism, and catastrophic cell death.Necroptotic cell death in failing heart: relevance and proposed mechanisms.Expression and reconstitution of the bioluminescent Ca(2+) reporter aequorin in human embryonic stem cells, and exploration of the presence of functional IP3 and ryanodine receptors during the early stages of their differentiation into cardiomyocyteEvidence of necroptosis in hearts subjected to various forms of ischemic insults.The in vivo evidence for regulated necrosis.Necroptosis: A Novel Cell Death Modality and Its Potential Relevance for Critical Care Medicine.
P2860
Q24613714-CF3338B0-7563-4DB5-883C-26BD7071B3EBQ26751108-17FDFB33-868D-4FA8-80D4-EE530333194BQ26830515-C094B5BD-67F9-4924-809D-67C71CC97D25Q27021740-2FFCA214-750C-425B-9D13-3D11A363FFBEQ28083902-4CC07E4E-ACDE-4A9C-AEAF-13BEF52E6273Q28115154-43DE83AD-DF92-42E2-AEBB-34C91FBA2FF9Q28389478-26A85666-F51B-44F9-AA69-714429ACA39DQ30009153-F0DE5539-3BF9-40BC-9DCC-4ECE89DC6562Q33570328-68938122-BF26-4426-B11A-AA4D27988161Q33604010-A821BF6E-1EF4-4F5A-B138-CD37237C0367Q34252212-0A90BEAE-BA02-45F4-B78A-E241885AC27EQ34627513-897B6FD4-79F0-4C56-ACB9-0B7AB94FCD64Q34924104-B5961E78-E9AC-48DA-9FC6-C322CE33F692Q35038704-78F40D6D-6B5B-4D9E-B914-B4AA9E94F604Q35123520-75599209-ECBF-4B2F-8DE7-3A961FBF43C2Q35657122-97A54FD9-D1BD-44E3-AA7D-3BB356669E02Q35659441-90417B5E-DC58-4F0A-A880-8B499F2AA829Q35781653-CC949C0E-ED5A-4FD0-BF2F-2D293F3244C0Q35832660-99535E10-4CB2-4BF1-AE1E-1EA04331915DQ35972276-02BB22D0-B86F-4E87-85F6-A734B1D862EAQ35994637-CA733B10-4B82-421B-8A3C-9AF7F3351827Q36394948-0BCECB2D-997A-4A9A-993A-6A4637C46150Q36525166-83BC42D9-5FE1-4BA0-9D11-A678CEFAAC6FQ37250709-705728F1-F56B-48E9-A5F3-DC905A229D9CQ37330076-FB48520B-E2B3-482C-ACD8-D17D51F4ADAEQ37350004-D2DF6AED-5C60-43DD-BFDE-1661DB58043CQ37631323-5DBEA816-1B99-4A78-9679-EAC0CE035A06Q37686255-81DF2904-6B6B-4425-8631-A590371F35B6Q37724332-16CBE586-DB1B-4B93-9D5B-E5FD47D4CC2DQ37874707-39CFC67A-485F-4149-8009-D5950840DC84Q37902989-15DB3B05-0221-4EF6-8793-C0BB65234EB3Q38119187-9EC2AEA0-AA95-407E-8C6D-E845CD026792Q38370240-CE16E957-5241-49BD-88A1-F2B31DB49084Q38543416-3B697700-9945-46F7-BBD6-D3CBE5163E93Q38699105-17565627-2632-4343-A937-1A9300C6E918Q38731479-651EF890-4408-4F26-B781-22900FD198FAQ38757346-0DC36B69-D51A-4D19-ABDB-7DF10F338649Q38803858-9D629106-4DC9-471B-BB7D-A9E03FFCA5DDQ38809791-5FDB33FC-C0B9-4514-9119-B6896CA9C439Q38861198-649E0739-FD19-4353-960F-CE704501B38E
P2860
The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The cardioprotective effect of ...... l permeability transition pore
@ast
The cardioprotective effect of ...... l permeability transition pore
@en
type
label
The cardioprotective effect of ...... l permeability transition pore
@ast
The cardioprotective effect of ...... l permeability transition pore
@en
prefLabel
The cardioprotective effect of ...... l permeability transition pore
@ast
The cardioprotective effect of ...... l permeability transition pore
@en
P2093
P2860
P1476
The cardioprotective effect of ...... l permeability transition pore
@en
P2093
C C T Smith
D M Yellon
M M Mocanu
S M Davidson
P2860
P304
P356
10.1007/S10557-007-6067-6
P577
2007-12-01T00:00:00Z